ResearcherQuzhou City People's HospitalNo recent work listed
Tian Lan
Matched on ORCID iD 0000-0003-0462-8690; OpenAlex author ID A5101686153.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2023: 2 papers
Papers 2
- YEATS2 regulates the activation of TAK1/NF-κB pathway and is critical for pancreatic ductal adenocarcinoma cell survival. Co-author DOI 10.1007/s10565-021-09671-4↗
- Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis. First author DOI 10.1016/j.phymed.2022.154564↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Feng Zhang · 2 shared papers, 2023
- Paper Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis. DOI 10.1016/j.phymed.2022.154564↗
- Paper YEATS2 regulates the activation of TAK1/NF-κB pathway and is critical for pancreatic ductal adenocarcinoma cell surviva… DOI 10.1007/s10565-021-09671-4↗
- Hao Sheng · 1 shared paper, 2023
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.